Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-19,187
Closed -$1.8M 4297
2025
Q3
$1.61M Buy
+19,187
New +$1.58M ﹤0.01% 2388
2025
Q1
Sell
-18,557
Closed -$1.73M 3349
2024
Q4
$1.85M Buy
+18,557
New +$1.91M ﹤0.01% 1932
2024
Q3
Sell
-11,656
Closed -$1.38M 2950
2024
Q2
$1.44M Buy
+11,656
New +$1.5M ﹤0.01% 1755
2021
Q3
Sell
-25,724
Closed -$1.96M 1240
2021
Q2
$718K Buy
+25,724
New +$1.91M ﹤0.01% 967
2020
Q1
Sell
-50,141
Closed -$3.94M 877
2019
Q4
$4.35M Buy
50,141
+25,316
+102% +$2.08M 0.01% 367
2019
Q3
$1.99M Sell
24,825
-15,693
-39% -$1.26M 0.01% 460
2019
Q2
$3.24M Buy
+40,518
New +$3.1M 0.01% 346

Other funds holding MRK

IMC Chicago's MRK Position: Q4 2025 in Review

IMC Chicago sold out of Merck (MRK) in Q4 2025, closing a stake of 19,187 shares — an estimated $1.8M sold.

IMC Chicago first reported a position in MRK in Q2 2019 and held it in 7 quarters. The position peaked at $4.35M in Q4 2019. 3,656 funds tracked by Wall St. Rank hold MRK as of Q4 2025.

  • IMC Chicago reported no remaining Merck position as of Q4 2025 after selling out during the quarter.
  • IMC Chicago sold 19,187 Merck shares in Q4 2025, an estimated $1.8M.
  • IMC Chicago first reported a position in Merck in Q2 2019 and held it in 7 quarters.
  • IMC Chicago's Merck position peaked at $4.35M in Q4 2019.
  • 3,656 funds tracked by Wall St. Rank held Merck as of Q4 2025.

Based on IMC Chicago's 13F filing for Q4 2025, filed 29 Jan 2026.